Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Intracardiac thrombosis following intravenous zoledronate treatment in a child with steroid-induced osteoporosis.

< BACK TO ARCHIVE


2022 Nov 28


J Pediatr Endocrinol Metab


http://www.ncbi.nlm.nih.gov/pubmed/36427218?dopt=Abstract

Intracardiac thrombosis following intravenous zoledronate treatment in a child with steroid-induced osteoporosis.

Authors

Intracardiac thrombosis following intravenous zoledronate treatment in a child with steroid-induced osteoporosis.
Case SJ, Moon RJ, Bharucha T, Davies JH
J Pediatr Endocrinol Metab. 2022 Nov 28.
PMID: 36427218.

Abstract

Bisphosphonates are used in childhood osteoporosis but can cause an acute phase reaction (APR) and hypocalcemia. We present a child with cardiac thrombosis following zoledronate, a previously unreported complication.
Read This Paper